Riesgo de toxicidad medicamentosa                                             Risk of drug toxicity  

Yeh ML. Drug safeguards to ensure the ambulatory medication safety of elderly people. Hu Li Za Zhi. 2013; 60(2):24-31. doi: 10.6224/JN.60.2.24.

Smyth RM, Gargon E, Kirkham J, Cresswell L, Golder S, Smyth R, Williamson P. Adverse drug reactions in children: a systematic review. PLoS One. 2012;7(3):e24061.

Poonai N, Alawi K, Rieder M, Lynch T, Lim R. A comparison of amethocaine and liposomal lidocaine cream as a pain reliever before venipuncture in children: a randomized control trial. Pediatr Emerg Care. 2012; 28(2):104-8.

Armstrong TS, Wen PY, Gilbert MR, Schiff D. Management of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumors. Neuro Oncol. 2012; 14(10):1203-14.

Steenbeek A, Macdonald N, Downie J, Appleton M, Baylis F. Ill-informed consent? A content analysis of physical risk disclosure in school-based HPV vaccine programs. Public Health Nurs. 2012; 29(1):71-9.

Can G, Aydiner A, Cavdar I. Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity. Eur J Oncol Nurs. 2012; 16(3):270-5.

Boucher J, Olson L, Piperdi B. Preemptive management of dermatologic toxicities associated with epidermal growth factor receptor inhibitors. Clin J Oncol Nurs. 2011; 15(5):501-8.

Macedo AF, Alves C, Craveiro N, Marques FB. Multiple drug exposure as a risk factor for the seriousness of adverse drug reactions. J Nurs Manag. 2011;19(3):395-9.

Gabe ME, Davies GA, Murphy F, Davies M, Johnstone L, Jordan S. Adverse drug reactions: treatment burdens and nurse-led medication monitoring. J Nurs Manag. 2011; 19(3):377-92.

Nash M. Improving mental health service users' physical health through medication monitoring: a literature review. J Nurs Manag. 2011; 19(3):360-5.

Nemeth LS, Wessell AM. Improving medication safety in primary care using electronic health records. J Patient Saf. 2010; 6(4):238-43.

Jylhä V, Saranto K, Bates DW. Preventable adverse drug events and their causes and contributing factors: the analysis of register data. Int J Qual Health Care. 2011; 23(2):187-97.

Drinkwater J. Magnesium sulphate for pre-eclampsia: care of the neonate. Pract Midwife. 2011; 14(11):17-9.

Valente S, Murray LP. Creative strategies to improve patient safety: allergies and adverse drug reactions. J Nurses Staff Dev. 2011;27(1):E1-5.

Howland RH. Potential adverse effects of discontinuing psychotropic drugs. Part 3: Antipsychotic, dopaminergic, and mood-stabilizing drugs. J Psychosoc Nurs Ment Health Serv. 2010; 48(8):11-4.

Choo J, Hutchinson A, Bucknall T. Nurses' role in medication safety. J Nurs Manag. 2010; 18(7):853-61.

Snyder RA, Fields W. A model for medication safety event detection. Int J Qual Health Care. 2010; 22(3):179-86.

Lynch MP, Marcone D, King J. Chemotherapy follow-up in older adults: results of a quality-improvement project. Clin J Oncol Nurs. 2010; 14(5):619-25.

Secoli SR, Pérez-Esquirol E, de Las Heras-Matellán MJ, Vendrell-Bosh L, Ballarín-Alins E. Incompatibilities in intravenous therapy: What can be done to prevent them?. Enferm Clin. 2009; 19(6):349-53.

Howland RH. Evaluating the safety of medications during pregnancy and lactation. J Psychosoc Nurs Ment Health Serv. 2009; 47(3):19-22.

Perng SJ, Lee LL, Sung HC. Chemical toxicants and preconception health: the role of nurses. Hu Li Za Zhi. 2008; 55(6):17-21.

Howland RH. Lisdexamfetamine: a prodrug stimulant for ADHD. J Psychosoc Nurs Ment Health Serv. 2008; 46(8):19-22. 

Versión para imprimir Versión para imprimir | Mapa del sitio